| Health / Medical Topics |
Farletuzumab
A humanized, immunoglobulin G1 monoclonal antibody with potential antitumor activity. Farletuzumab specifically targets at glycoprotein 3 (GP-3), a cell surface antigen that is overexpressed on many epithelial-derived cancer cells. Upon binding to the GP-3 antigen, farletuzumab triggers a host immune response against GP-3 expressing cells resulting in cell lysis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A drug being studied in the treatment of cancer. It blocks enzymes needed for cells to grow and divide and may kill…
An L-tyrosine derived and peroxisome proliferator-activated receptor (PPAR) agonist with hypoglycemic and lipid lowering activity. Farglitazar shows greater selectivity over PPARgamma than…
A very rare autosomal recessive metabolic disorder affecting lipid metabolism. It is caused by mutations in the ASAH1 gene and is characterized…
A constant used also as a unit of electric charge representing the electric charge carried by one mole (an Avogadro's number) of…
A SI unit of electric permittivity.
A SI unit of capacitance equal to the capacitance of a capacitor having an equal and opposite charge of one coulomb on…
